About KaloCyte
KaloCyte is a company based in St. Louis (United States) founded in 2016 by Dipanjan Pan, Philip Spinella, and Allan Doctor.. KaloCyte has raised $1.1 million across 6 funding rounds from investors including HHS, NYBC Ventures and Maryland Momentum Fund. KaloCyte offers products and services including ErythroMer. KaloCyte operates in a competitive market with competitors including Satellite Bio, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others.
- Headquarter St. Louis, United States
- Founders Dipanjan Pan, Philip Spinella, Allan Doctor
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kalocyte, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.1 M (USD)
in 6 rounds
-
Latest Funding Round
$2.46 M (USD), Grant
Apr 15, 2024
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KaloCyte
KaloCyte offers a comprehensive portfolio of products and services, including ErythroMer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Dried substitute for red blood cells in trauma and emergencies.
Unlock access to complete
Funding Insights of KaloCyte
KaloCyte has successfully raised a total of $1.1M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.46 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.5M
-
First Round
First Round
(11 May 2017)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Grant - KaloCyte | Valuation |
investors |
|
| Jul, 2022 | Amount | Seed - KaloCyte | Valuation |
investors |
|
| Jun, 2020 | Amount | Seed - KaloCyte | Valuation | Maryland Momentum Fund |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KaloCyte
KaloCyte has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, NYBC Ventures and Maryland Momentum Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment funding is provided for University System of Maryland ventures.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KaloCyte
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KaloCyte
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kalocyte Comparisons
Competitors of KaloCyte
KaloCyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Satellite Bio, CorNeat Vision, Stratatech Corp, Morphocell Technologies and Haimai Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Proprietary implantable satellite organs are developed for cell therapy.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| domain | founded_year | HQ Location |
Cell-based skin substitutes are developed for therapeutic and research uses.
|
|
| domain | founded_year | HQ Location |
Engineered liver tissues are developed for liver disease treatments.
|
|
| domain | founded_year | HQ Location |
Tissue engineering technologies for cardiovascular regenerative surgeries are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kalocyte
Frequently Asked Questions about KaloCyte
When was KaloCyte founded?
KaloCyte was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is KaloCyte located?
KaloCyte is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Is KaloCyte a funded company?
KaloCyte is a funded company, having raised a total of $1.1M across 6 funding rounds to date. The company's 1st funding round was a Seed of $300K, raised on May 11, 2017.
What does KaloCyte do?
KaloCyte was founded in 2016 in St. Louis, United States, within the biotechnology sector. A nanotechnology platform is utilized to create ErythroMer, an immuno-silent nanoparticle designed to mimic red blood cell surfaces and facilitate oxygen binding and gas exchange. The technology is directed toward trauma care in low-resource environments, such as battlefields and remote areas, to address blood loss mortality. Operations focus on advancing this substitute for clinical applications.
Who are the top competitors of KaloCyte?
KaloCyte's top competitors include Satellite Bio, Stratatech Corp and Morphocell Technologies.
What products or services does KaloCyte offer?
KaloCyte offers ErythroMer.
Who are KaloCyte's investors?
KaloCyte has 3 investors. Key investors include HHS, NYBC Ventures, and Maryland Momentum Fund.